Dr. Rahul Bhargava
Oncology and Bone Marrow Transplant.
MD, DM (Hematology) AIIMS
Dr. Rahul Bhargava is a leading bone marrow transplantation specialist and clinical hematologist. He is known for excellent patient outcomes and this has earned him the reputation of being among the best of his generation in this field of specialisation.
Dr. Bhargava is a DM (Hematology) which is the highest academic degree in hematology from AIIMS the India’s most reputed instituteand has impressive training credentials. After an initial two-year stint at the Christian Medical College, Vellore – a centre widely regarded as the cradle of hematology and bone marrow transplantationin India – under the famed Prof. Mammen Chandy, he moved to the All India Institute of Medical Sciences (AIIMS) in New Delhi for a formal three-year superspecialist degree of DM in Clinical Hematology. Subsequently, Dr. Bhargava was selected for a fellowship in Vancouver, Canada, and underwent specific training in voluntary stem cell and umbilical cord transplantation.
Upon his return to India, Dr. Rahul Bhargava joined Medanta Medicity in Gurgaon. He developed its bone marrow transplantation and hematology services from the ground up, completing 100 transplants in a period of 36 months in the then new hospital that soon became one of the largest medical centres in the country. After that he set up the BMT unit at Artemis Hospital succesfully.
Dr. Bhargava currently heads the Hematology and bone marrow transplantation department at Fortis FMRI Hospital in Gurgaon. The department has its own transplantation unit and extensive laboratory facilities, providing cutting-edge clinical skills and the latest in technology at affordable costs for transplantation and other hematological services. Till date, Dr. Bhargava has performed close to 300 adult bone marrow transplantation, an industry leading performance in north India.
Hematology and Bone Marrow Transplantation
Research Work ::
- Doctoral Thesis on “Thyroid Dysfunction in Patients of Chronic Renal Failure
- Oral Antifungal Prophylaxis in Neutropenic Patients with Hematological
- Malignancies: Randomized Controlled Trial of Oral itraconazole versus Fluconazole
- Platelet Dysfunction In Myeloproliferative Disorder Excluding CML